Literature DB >> 22415581

Elimination therapy for the endemic malarias.

J Kevin Baird1.   

Abstract

Most malaria diagnosed outside endemic zones occurs in patients experiencing the consequences of what was likely a single infectious bite by an anopheline mosquito. A single species of parasite is nearly always involved and expert opinion on malaria chemotherapy uniformly prescribes species- and stage-specific treatments. However the vast majority of people experiencing malaria, those resident in endemic zones, do so repeatedly and very often with the involvement of two or more species and stages of parasite. Silent forms of these infections-asymptomatic and beyond the reach of diagnostics-may accumulate to form substantial and unchallenged reservoirs of infection. In such settings treating only the species and stage of malaria revealed by diagnosis and not others may not be sensible or appropriate. Developing therapeutic strategies that address all species and stages independently of diagnostic evidence may substantially improve the effectiveness of the control and elimination of endemic malaria.

Entities:  

Year:  2012        PMID: 22415581      PMCID: PMC3342493          DOI: 10.1007/s11908-012-0250-z

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  55 in total

Review 1.  Amazonian malaria: asymptomatic human reservoirs, diagnostic challenges, environmentally driven changes in mosquito vector populations, and the mandate for sustainable control strategies.

Authors:  Mônica da Silva-Nunes; Marta Moreno; Jan E Conn; Dionicia Gamboa; Shira Abeles; Joseph M Vinetz; Marcelo U Ferreira
Journal:  Acta Trop       Date:  2011-10-12       Impact factor: 3.112

2.  Prevalence, risk factors and treatment-seeking behaviour for malaria: the results of a case study from the Terai region of West Bengal, India.

Authors:  S Mazumdar
Journal:  Ann Trop Med Parasitol       Date:  2011-04

3.  Treating common illnesses among children under five years: a portrayal of health-seeking behaviours and practices in the northern areas of Pakistan.

Authors:  Babar T Shaikh; Dave Haran
Journal:  World Health Popul       Date:  2011

4.  Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua.

Authors:  Mazie J Barcus; Hasan Basri; Helena Picarima; C Manyakori; Iqbal Elyazar; Michael J Bangs; Jason D Maguire; J Kevin Baird
Journal:  Am J Trop Med Hyg       Date:  2007-11       Impact factor: 2.345

5.  Sub-microscopic malaria cases and mixed malaria infection in a remote area of high malaria endemicity in Rattanakiri province, Cambodia: implication for malaria elimination.

Authors:  Nicolas Steenkeste; William O Rogers; Lucy Okell; Isabelle Jeanne; Sandra Incardona; Linda Duval; Sophy Chy; Sean Hewitt; Monidarin Chou; Duong Socheat; François-Xavier Babin; Frédéric Ariey; Christophe Rogier
Journal:  Malar J       Date:  2010-04-22       Impact factor: 2.979

6.  A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting.

Authors:  Ivor Harris; Wesley W Sharrock; Lisa M Bain; Karen-Ann Gray; Albino Bobogare; Leonard Boaz; Ken Lilley; Darren Krause; Andrew Vallely; Marie-Louise Johnson; Michelle L Gatton; G Dennis Shanks; Qin Cheng
Journal:  Malar J       Date:  2010-09-07       Impact factor: 2.979

7.  Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.

Authors:  Frank Smithuis; Moe Kyaw Kyaw; Ohn Phe; Thein Win; Pyay Phyo Aung; Aung Pyay Phyo Oo; Arkar Linn Naing; Mya Yee Nyo; Naing Zaw Htun Myint; Mallika Imwong; Elizabeth Ashley; Sue J Lee; Nicholas J White
Journal:  Lancet Infect Dis       Date:  2010-09-09       Impact factor: 25.071

8.  Awareness, attitudes and prevention of malaria in the cities of Douala and Yaoundé (Cameroon).

Authors:  Cyrille Ndo; Benjamin Menze-Djantio; Christophe Antonio-Nkondjio
Journal:  Parasit Vectors       Date:  2011-09-20       Impact factor: 3.876

9.  Socially-marketed rapid diagnostic tests and ACT in the private sector: ten years of experience in Cambodia.

Authors:  Shunmay Yeung; Edith Patouillard; Henrietta Allen; Duong Socheat
Journal:  Malar J       Date:  2011-08-18       Impact factor: 2.979

10.  Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop.

Authors:  N Mühlberger; T Jelinek; J Gascon; M Probst; T Zoller; M Schunk; J Beran; I Gjørup; R H Behrens; J Clerinx; A Björkman; P McWhinney; A Matteelli; R Lopez-Velez; Z Bisoffi; U Hellgren; S Puente; M L Schmid; B Myrvang; M L Holthoff-Stich; H Laferl; C Hatz; H Kollaritsch; A Kapaun; J Knobloch; J Iversen; A Kotlowski; D J M Malvy; P Kern; G Fry; H Siikamaki; M H Schulze; G Soula; M Paul; J Gómez i Prat; V Lehmann; O Bouchaud; S da Cunha; J Atouguia; G Boecken
Journal:  Malar J       Date:  2004-03-08       Impact factor: 2.979

View more
  4 in total

Review 1.  Evidence and implications of mortality associated with acute Plasmodium vivax malaria.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

2.  Reinventing primaquine for endemic malaria.

Authors:  John Kevin Baird
Journal:  Expert Opin Emerg Drugs       Date:  2012-09-21       Impact factor: 4.191

3.  Severe morbidity and mortality risk from malaria in the United States, 1985-2011.

Authors:  Jimee Hwang; Karen A Cullen; S Patrick Kachur; Paul M Arguin; J Kevin Baird
Journal:  Open Forum Infect Dis       Date:  2014-06-30       Impact factor: 3.835

4.  Spatial distribution of G6PD deficiency variants across malaria-endemic regions.

Authors:  Rosalind E Howes; Mewahyu Dewi; Frédéric B Piel; Wuelton M Monteiro; Katherine E Battle; Jane P Messina; Anavaj Sakuntabhai; Ari W Satyagraha; Thomas N Williams; J Kevin Baird; Simon I Hay
Journal:  Malar J       Date:  2013-11-15       Impact factor: 2.979

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.